Retrospective Study of Incidence and Etiology of Reoperation After Primary Augmentation With Natrelle® Breast Implants

Inclusion Criteria: * Primary breast augmentation (either bilateral or unilateral) operated on by the investigating surgeon with an infra-mammary approach 410 cohesive BIOCELL™ textured device (Truform 2 \& 3 only) has been implanted * Primary breast augmentation 3 to 10 years prior to data collection * Submuscular/dual plane or subglandular implant placement Exclusion Criteria: * Breast augmentation for Poland Syndrome or amastia * Breast reconstruction following mastectomy * Revision or secondary breast reconstruction * Non 410 device at initial breast augmentation * Women subsequently diagnosed with fibrocystic disease considered to be pre-malignant * Procedures of the breast not related to the primary breast augmentation (e.g. excision of skin lesions) * Axillary or peri-areolar approach * Glandular mastopexy augmentation (skin excision only)